Canagliflozin Pretreatment Attenuates Myocardial Dysfunction and Improves Postcardiac Arrest Outcomes After Cardiac Arrest and Cardiopulmonary Resuscitation in Mice
ConclusionsCanagliflozin offered a strong cardioprotective effect against cardiac arrest and resuscitation-induced cardiac dysfunction. This canagliflozin-induced cardioprotection is mediated by the STAT-3-dependent cell-survival signaling pathway.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Arrhythmia | Brain | Canagliflozin | Cardiology | Cardiovascular | Chloride | Diabetes | Diabetes Type 2 | Electrocardiogram | Endocrinology | Heart | Invokana | Klor-Con | Neurology | Potassium | Potassium Chloride | SGLT2 Inhibitors | Study